Washington, Sept 27 : A team of two British scientists have conceptualised a radical plan that calls for placing giant pumps in the ocean to pump up cold, nutrient-rich water from deep below, encouraging surface algae to bloom and suck carbon dioxide from the atmosphere.

James Lovelock and Chris Rapley claim that such climate engineering solutions might be the only way to hold global warming at bay given its current progress.

Washington, Sept 27: Experimental drug axitinib has been found to have potential to bring respite to patients with advanced kidney cancer, whose options run out after their tumour fails to respond to the cutting edge therapy.

The study, led by Dr Brian I. Rini an associate professor of medicine at the Cleveland Clinic Taussig Cancer Institute in Cleveland, Ohio, USA, and a paid member of the Pfizer scientific advisory board, demonstrated that the drug shrank tumours, and delayed the disease’s progression.

Washington, September 27 : People who drink can significantly reduce their likelihood of suffering from cancers of head and neck by quitting alcohol consumption, a research at the Centre for Addiction and Mental Health (CAMH) has suggested.

Principal Investigator Dr. Jurgen Rehm says that his study has shown an association between alcohol consumption and an increased risk for cancer of the oesophagus, larynx and oral cavity.

Washington, September 27 : Researchers at the University of California, Riverside say that plants can be used to study why prescription medications work successfully to cure an ailment in some people, while the same dose of the same drug can cause an adverse reaction in others.

“The genetics behind variable drug responses is not peculiar to humans but exists also in other branches on the tree of life,” Nature Chemical Biology quoted Sean Cutler, an assistant professor of plant cell biology at UC Riverside, as saying.

Washington, Sept 27 : Though cancer patients and health specialists believe that acupuncture offers relief from radiotherapy-induced nausea, a new study has revealed that it does not.

Washington, Sept 27: According to a new study a new molecular target in blood clot formation has been found which may help to reduce clotting without any excessive bleeding.

unveils a new molecular target for anti-platelet drugs, which may avoid the dangerous side-effects of the current drugs."

The study, led by Shafi Kuchay and Dr. Athar Chishti, was made at the University of Illinois at Chicago College of Medicine.